BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 640330)

  • 1. [Isoniazid-rifampicin: an exemplary hepatotoxicity].
    Berthelot P
    Gastroenterol Clin Biol; 1978 Feb; 2(2):129-32. PubMed ID: 640330
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of isoniazid in hepatotoxicity with the INH-rifampicin combination in tuberculosis in children].
    Dieu MJ
    J Med Lyon; 1972 Oct; 53(234):1323-4 passim. PubMed ID: 4539047
    [No Abstract]   [Full Text] [Related]  

  • 3. [Synergistic effect of rifampicin on hepatotoxicity of isoniazid].
    Skakun NP; Shman'ko VV
    Antibiot Med Biotekhnol; 1985 Mar; 30(3):185-9. PubMed ID: 4015060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic toxicity of antituberculous drugs in children.
    Allué X; Sanjurjo P; Fidalgo I; Bilbao F
    Helv Paediatr Acta; 1976 Dec; 31(4-5):381-7. PubMed ID: 1017983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination].
    Rossolini A; Cellesi C; Debolini A
    Farmaco Prat; 1973 Jun; 28(6):345-55. PubMed ID: 4714054
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatic dysfunction in tuberculous patients treated with rifampicin and isoniazid.
    Burke M; Logan J
    Ir Med J; 1979 Oct; 72(10):430-4. PubMed ID: 500344
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatotoxicity in rifampin-isoniazid treated patients related to their rate of isoniazid inactivation.
    Smith J; Tyrell WF; Gow A; Allan GW; Lees AW
    Chest; 1972 Jun; 61(6):587-8. PubMed ID: 5032153
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatotoxicity of the rifampicin-isoniazid combination in children].
    Bonora G; De La Pierre L; Perletti L
    Minerva Pediatr; 1981 Aug; 33(16):835-6. PubMed ID: 7311946
    [No Abstract]   [Full Text] [Related]  

  • 9. Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction.
    Pessayre D; Bentata M; Degott C; Nouel O; Miguet JP; Rueff B; Benhamou JP
    Gastroenterology; 1977 Feb; 72(2):284-9. PubMed ID: 830577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The hepatotoxicity of rifampicin and its modification through "essential" choline phospholipids].
    Kuntz HD; Rausch V; Bammel E
    Med Welt; 1978 Mar; 29(11):452-4. PubMed ID: 651600
    [No Abstract]   [Full Text] [Related]  

  • 11. Isoniazid-rifampicin-induced submassive hepatic necrosis.
    Kasantikul V
    J Med Assoc Thai; 1989 Jan; 72(1):56-8. PubMed ID: 2723568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of adverse reactions of chronic drug therapy as examplified with the hepatotoxic action of isoniazid and rifampicin].
    Bartmann K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1518-29. PubMed ID: 347784
    [No Abstract]   [Full Text] [Related]  

  • 13. [Detection of the effects of the rifampin-isoniazid combination on the human liver].
    Plomteux G; Heusghem C; Ferdinande R; Lecoq A; Winandy A; Parmentier JC
    Nouv Presse Med; 1974 Mar; 3(12):727-32. PubMed ID: 4836506
    [No Abstract]   [Full Text] [Related]  

  • 14. [Isoniazid-rifampicin: a model for hepatotoxicity and for bibliographic Anglomania].
    Toulet J; Viteau JM
    Gastroenterol Clin Biol; 1978; 2(8-9):756-7. PubMed ID: 361483
    [No Abstract]   [Full Text] [Related]  

  • 15. [Increase in transaminases and jaundice during treatment with rifampicin combined with isoniazid].
    Kreis B; Boutonnet G
    Rev Tuberc Pneumol (Paris); 1970 Dec; 34(8):1097-106. PubMed ID: 5517156
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
    Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F
    Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatotoxicity of the combination of isoniazid-rifampicin in African children. Role of malnutrition and HB virus].
    Gendrel D; Nardou M; Mouba JF; Gahouma D; Moussavou A; Boguikouma JB
    Arch Fr Pediatr; 1989 Nov; 46(9):645-8. PubMed ID: 2604523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatotoxicity of rifampicin and isoniazid in children.
    Casteels-Van Daele M; Igodt-Ameye L; Corbeel L; Eeckels R
    J Pediatr; 1975 May; 86(5):739-41. PubMed ID: 1079531
    [No Abstract]   [Full Text] [Related]  

  • 19. [The liver and rifampicin].
    Blanchon P; Paillas J; Holler A; Groseille Y; Blanchon B; Blanchon F
    Poumon Coeur; 1973; 29(6):739-52. PubMed ID: 4370583
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatotoxicity of rifampin and isoniazid. Is it all drug-induced hepatitis?
    Kumar A; Misra PK; Mehotra R; Govil YC; Rana GS
    Am Rev Respir Dis; 1991 Jun; 143(6):1350-2. PubMed ID: 1904700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.